CIBA CORNING ACS PSA IMMUNOASSAY

FDA Premarket Approval P920030

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

DeviceCIBA CORNING ACS PSA IMMUNOASSAY
Generic NameProstate-specific Antigen (psa) For Management Of Prostate Cancers
ApplicantBAYER HEALTHCARE, LLC
Date Received1992-06-26
Decision Date1998-12-08
Notice Date1994-10-27
PMAP920030
SupplementS
Product CodeLTJ 
Docket Number94M-0349
Advisory CommitteeImmunology
Expedited ReviewNo
Combination Product No
Applicant Address BAYER HEALTHCARE, LLC 511 Benedict Ave. tarrytown, NY 10591

Supplemental Filings

Supplement NumberDateSupplement Type
P920030Original Filing
S002 1998-04-20 Panel Track
S001 1995-09-14 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.